Qureight is a Cambridge-based company which uses cloud-based technology to assist in the structuring of image and paired clinical metadata in complex diseases. By structuring data in this way, it allows for the development of AI-based tools to better understand diseases including lung fibrosis, complex cancers and covid-19. Clients using the Qureight platform include the drug companies Takeda, Galapagos and Roche.